Versor Investments’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Versor Investments’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-436,935	Closed	-$20.3M	–	873
2023 Q2	$20.3M	Buy	436,935 +426,935	+4,269%	+$14.8M	3.52%	3
2023 Q1	$286K	Buy	+10,000	New	+$296K	0.04%	512

Versor Investments's DICE Position: Q3 2023 in Review

Versor Investments sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 436,935 shares — an estimated $20.3M sold.

Versor Investments first reported a position in DICE in Q1 2023 and held it in 2 quarters. The position peaked at $20.3M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Versor Investments reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Versor Investments sold 436,935 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $20.3M.
Versor Investments first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Versor Investments's DICE Therapeutics, Inc. Common Stock position peaked at $20.3M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Versor Investments's 13F filing for Q3 2023, filed 6 Nov 2023.